These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27517625)

  • 1. CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy.
    Ulasov IV; Kaverina NV; Ghosh D; Baryshnikova MA; Kadagidze ZG; Karseladze AI; Baryshnikov AY; Cobbs CS
    Oncotarget; 2017 Apr; 8(16):25989-25999. PubMed ID: 27517625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
    Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
    J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus gene expression in long-term infected glioma stem cells.
    Fiallos E; Judkins J; Matlaf L; Prichard M; Dittmer D; Cobbs C; Soroceanu L
    PLoS One; 2014; 9(12):e116178. PubMed ID: 25549333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
    Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
    Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
    Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
    PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.
    Guerra-Rebollo M; Garrido C; Sánchez-Cid L; Soler-Botija C; Meca-Cortés O; Rubio N; Blanco J
    Sci Rep; 2019 Jul; 9(1):9549. PubMed ID: 31267022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
    Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
    Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus as an oncomodulatory agent in the progression of glioma.
    Joseph GP; McDermott R; Baryshnikova MA; Cobbs CS; Ulasov IV
    Cancer Lett; 2017 Jan; 384():79-85. PubMed ID: 27777041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Glioma Cells Exhibit Stem Cell-like Properties.
    Liu T; Xu H; Huang M; Ma W; Saxena D; Lustig RA; Alonso-Basanta M; Zhang Z; O'Rourke DM; Zhang L; Gong Y; Kao GD; Dorsey JF; Fan Y
    Cancer Res; 2018 Dec; 78(23):6632-6642. PubMed ID: 30322863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades.
    Stangherlin LM; Castro FL; Medeiros RS; Guerra JM; Kimura LM; Shirata NK; Nonogaki S; Dos Santos CJ; Carlan Silva MC
    PLoS One; 2016; 11(7):e0159604. PubMed ID: 27458810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma.
    Chiou GY; Chien CS; Wang ML; Chen MT; Yang YP; Yu YL; Chien Y; Chang YC; Shen CC; Chio CC; Lu KH; Ma HI; Chen KH; Liu DM; Miller SA; Chen YW; Huang PI; Shih YH; Hung MC; Chiou SH
    Mol Cell; 2013 Dec; 52(5):693-706. PubMed ID: 24332177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
    Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
    Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.
    Deshpande RP; Panigrahi M; Y B V K C; Babu PP
    Neurol Sci; 2018 Nov; 39(11):1895-1902. PubMed ID: 30090984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.